Akèy › Kansè Sistèm Dijestif › Ohio
Etid klinik pou Kansè Sistèm Dijestif nan Ohio
4 etid pou Kansè Sistèm Dijestif ap chèche patisipan nan sit nan Ohio.
Tèks ofisyèl etid la (Anglè)
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Oncology Hematology Care - Eastgate, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- Oncology Hematology Care Clinical Trials, LLC, Fairfield
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
- Cleveland Clinic, Cleveland
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT07406633A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- The Ohio State University Wexner Medical Center, Columbus
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT03093116A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
- USA03-0, Cincinnati
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT07263594Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.